A Biochip For The Simultaneous Detection Of All Fertility Hormones Has Brought Cost And Time Savings To Routine Diagnostics
Measurement of all fertility hormones is usually performed between day 3 and 5 of a women’s hormonal cycle for the diagnosis of menorrhea problems, onset of menopause and infertility. Having to perform each test separately has cost and time implications. Randox has developed a platform where multiple analytes can be tested simultaneously on a biochip with a small quantity of blood. [click link for full article]
More: continued here
Filed under: Fertility on December 24th, 2007